Li Pang1, Yang Wu1, Ning Dong1, Da-hai Xu1, Da-wei Wang1, Zhi-hao Wang1, Xing-liang Li1, Miao Bian2, Hui-jie Zhao2, Xiao-liang Liu1, Nan Zhang3. 1. Department of Emergency, The First Affiliated Hospital of Jilin University, Changchun, Jilin, PR China. 2. Department of Respiratory, Qianwei Hospital of Jilin Province, Changchun, Jilin, PR China. 3. Department of Emergency, The First Affiliated Hospital of Jilin University, Changchun, Jilin, PR China. Electronic address: 466634002@qq.com.
Abstract
OBJECTIVE: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage after acute neurologic insults, such as ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury. However, the effect of serum UCH-L1 levels has not been investigated in carbon monoxide (CO)-poisoned patients. The aim of the present study was to evaluate whether serum UCH-L1 levels are a reliable marker of brain damage and the association of UCH-L1 with outcome. DESIGN AND METHODS: This case-control study enrolled 46 CO-poisoned subjects and 30 controls. Using an enzyme-linked immunosorbent assay (ELISA) kit, we studied the temporal profile of serum UCH-L1 levels at 6, 12, 24 and 48 h after acute CO poisoning. Poisoning severity was assessed using the Glasgow Coma Scale (GCS) score. Long-term outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months after poisoning. RESULTS: Compared with controls, CO-poisoned patients had significantly elevated serum levels of UCH-L1 at each time point after poisoning. There were significantly higher levels of UCH-L1 in CO-poisoned patients with a lower GCS score as well as in those with a poor 6-month outcome dichotomized GOS. CONCLUSIONS: Serum levels of UCH-L1 appear to have potential clinical utility in providing valuable information about poisoning severity and outcome after CO poisoning.
OBJECTIVE:Ubiquitin C-terminal hydrolase-L1 (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage after acute neurologic insults, such as ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury. However, the effect of serum UCH-L1 levels has not been investigated in carbon monoxide (CO)-poisoned patients. The aim of the present study was to evaluate whether serum UCH-L1 levels are a reliable marker of brain damage and the association of UCH-L1 with outcome. DESIGN AND METHODS: This case-control study enrolled 46 CO-poisoned subjects and 30 controls. Using an enzyme-linked immunosorbent assay (ELISA) kit, we studied the temporal profile of serum UCH-L1 levels at 6, 12, 24 and 48 h after acute CO poisoning. Poisoning severity was assessed using the Glasgow Coma Scale (GCS) score. Long-term outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months after poisoning. RESULTS: Compared with controls, CO-poisoned patients had significantly elevated serum levels of UCH-L1 at each time point after poisoning. There were significantly higher levels of UCH-L1 in CO-poisoned patients with a lower GCS score as well as in those with a poor 6-month outcome dichotomized GOS. CONCLUSIONS: Serum levels of UCH-L1 appear to have potential clinical utility in providing valuable information about poisoning severity and outcome after CO poisoning.
Authors: Håkon Haugaa; Hernando Gómez; Donald R Maberry; Andre Holder; Olufunmilayo Ogundele; Ana Maria B Quintero; Daniel Escobar; Tor Inge Tønnessen; Hannah Airgood; Cameron Dezfulian; Elizabeth Kenny; Sruti Shiva; Brian Zuckerbraun; Michael R Pinsky Journal: Crit Care Date: 2015-04-22 Impact factor: 9.097